Patient Reported Outcome Measures of Pharmaceutical Therapy for Quality of Life (PROPMPT-QOL) among Saudi Population: A Real World Observational Study

Pharmacy Practice

  • Hind M. AlOsaimi1Department of Pharmacy Services Administration, King Fahad Medical City, Riyadh Second Health Cluster, Riyadh, Saudi Arabia.
  • Rawabi Saad2Department of Medicine, Tabuk University, Tabuk, Saudi Arabia.
  • Turki G. Alalyani3Irada and Mental Health Complex, Ministry of Health, Al-Baha, Saudi Arabia.
  • Shatha S. Al-Majnooni4Department of Pharmaceutical Practices, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Kadi S. Alsubaie5College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
  • Amnnah A. Aljuwaiser6Department of Medicine, Aberdeen, Scotland, United Kingdom.
  • Sarah J. Al-Marashi7Department of Medicine, Taibah University, Madinah, Saudi Arabia.
  • Raghad F. Aljeaid8Department of Medicine, Almaarefa University, Riyadh, Saudi Arabia.
  • Rahaf A. Alzaidi9Faculty of Medicine, University of Jeddah, Jeddah, Saudi Arabia.
  • Abeer S. Almutairi10Social worker Department, Northern Area Armed Forces Hospital, King Khalid Military, Hafr Al Batin 31991, Kingdom of Saudi Arabia.
  • Razan S. Alsheikh11Department of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Deema S. Alkahmous12Department of Pharmacy, Almaarefa University, Diriyah, Saudi Arabia.
  • Abdularhman R. Almudayhish12Department of Pharmacy, Almaarefa University, Diriyah, Saudi Arabia.
  • Faisal M. Alanazi13College of Pharmacy, Northern Border University, Rafha, Saudi Arabia.
  • Mohammed Kanan14Department of Pharmaceutical Care, Rafha General Hospital, Rafha, Saudi Arabia.

Volume 23 Issue 2 Pages 1-8

DOI: 10.18549/PharmPract.2024.2.3126

Abstract

Introduction: Patient-reported outcomes in pharmaceutical therapy play a crucial role in understanding medication experiences and their impact on quality of life among chronic disease patients. This study aims to explore patient-reported outcomes in pharmaceutical therapy among chronic disease patients in Saudi Arabia, with a focus on medication experiences and their impact on quality of life. Methods: The study utilized a cross-sectional design, collecting self-reported data from participants recruited primarily from healthcare settings. Participants completed the PROMPT-QOL questionnaire, which assessed various domains related to medication use and quality of life. Results: The findings revealed positive attitudes towards medication use and perceived effectiveness among participants. However, they also reported experiencing various side effects and impacts, particularly in intimate aspects of life such as sexual desire or relationships, vision, hearing, speech, and social activities. Notably, participants placed significant value on clear and comprehensive medication information, indicating the importance of patient education in promoting adherence and satisfaction. Conclusion: The study underscores the critical role of effective information provision and holistic patient care in optimizing pharmaceutical therapy outcomes. Healthcare providers should prioritize patient education, foster therapeutic relationships, and involve patients in shared decision-making to enhance treatment outcomes and overall quality of life for chronic disease patients. Additionally, longitudinal and comparative studies are needed to further explore medication experiences and healthcare disparities across different populations and settings.

Keywords

  • PROMPT-QOL questionnaire
  • patient education
  • pharmaceutical therapy
  • foster therapeutic relationships
  • quality of life
Pharmacy Practice

Loading…